Phacilitate Leaders World


Lee Buckler

Lee Buckler

President & CEO, RepliCel Life Sciences Inc.

Lee Buckler has been an executive in the cell therapy sector since 2000 with past positions at Stem Cell Technologies' Malachite Management, International Society for Cellular Therapy, and Progenitor Cell Therapy.  Lee formed the business development consultancy, Cell Therapy Group, in 2008 where he serves clients both in and interested in the cell-based regenerative medicine industry.  Lee serves as co-chair of the Communications and Education Committee for the Alliance for Regenerative Medicine and is an active blogger (CellTherapyBlog), industry analyst, and social media contributor on both LinkedIn and Twitter (@celltherapy). Lee regularly publishes in industry trade publications and is a frequently invited conference speaker on cell therapy industry trends and metrics. He is on the editorial advisory board of the journal Regenerative Medicine, on the business advisory boards of BioCision and RoosterBio, and is a member of the Board of Directors for Hemostemix.  In 2010, Lee co-founded the quickly growing online recruiting support service and remains its Managing Director.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman